Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
0(0%)
Results Posted
29%(2 trials)

Phase Distribution

Ph phase_1
2
29%
Ph phase_2
4
57%
Ph phase_3
1
14%

Phase Distribution

2

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
2(28.6%)
Phase 2Efficacy & side effects
4(57.1%)
Phase 3Large-scale testing
1(14.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(7)

Detailed Status

Completed7

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (28.6%)
Phase 24 (57.1%)
Phase 31 (14.3%)

Trials by Status

completed7100%

Recent Activity

0 active trials
Showing 5 of 7
completedphase_2

Carboxyamidotriazole + RT in Treating Patients Newly Diagnosed Supratentorial GBM

NCT00004146
completedphase_3

Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer

NCT00003869
completedphase_2

Carboxyamidotriazole in Treating Patients With Advanced Kidney Cancer

NCT00005045
completedphase_2

Carboxyamidotriazole in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

NCT00019461
completedphase_1

Carboxyamidotriazole and Ketoconazole in Treating Patients With Advanced Cancers

NCT00003249
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT00004146Phase 2

Carboxyamidotriazole + RT in Treating Patients Newly Diagnosed Supratentorial GBM

Completed
NCT00003869Phase 3

Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer

Completed
NCT00005045Phase 2

Carboxyamidotriazole in Treating Patients With Advanced Kidney Cancer

Completed
NCT00019461Phase 2

Carboxyamidotriazole in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Completed
NCT00003249Phase 1

Carboxyamidotriazole and Ketoconazole in Treating Patients With Advanced Cancers

Completed
NCT00006486Phase 2

Carboxyamidotriazole in Treating Patients With Metastatic Kidney Cancer

Completed
NCT00019019Phase 1

Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7